GT1-7 hypothalamic neuronal cells (kindly provided by Pamela Mellon, UCSD)(Wetsel et al., 1991 (
link)), HCT116 USP7
+/+, USP7
+/−, USP7
−/− cells (kindly provided by Bert Vogelstein, Johns Hopkins University) (Cummins et al., 2004 (
link)),
HEK293 (ATCC),
HeLa Tet-ON (Clontech), or U2OS (ATCC) cells were grown in
DMEM (Invitrogen) supplemented with 10% FBS (Hyclone), 2 mM
L-Glutamine (Invitrogen), 100 units/ml
penicillin (Invitrogen), 100 mg/ml
streptomycin (Invitrogen), and 0.25 mg/ml
amphotericin B (Invitrogen). Plasmid and siRNA transfection were performed for 48-96 hours with
Effectene (QIAGEN) or
Lipofectamine RNAiMAX (Invitrogen), respectively, according to the manufacturer's protocol.
siRNAs (GE Dharmacon or Sigma) and antibodies used in this study are listed in the
supplemental experimental procedures. USP7 knockout GT1-7 cells were generated by cotransfection of plasmids encoding GFP-Cas9 and a gRNA plasmid targeting USP7 (5’-GGTTGCCTCGGAGCGCCAAC-3’). Forty-eight hours after transfection, cells were flow sorted for GFP-positive cells. USP7 disruption was confirmed by western blotting.
Hao Y.H., Fountain MD J.r., Tacer K.F., Xia F., Bi W., Kang S.H., Patel A., Rosenfeld J.A., Caignec C.L., Isidor B., Krantz I.D., Noon S.E., Pfotenhauer J.P., Morgan T.M., Moran R., Pedersen R.C., Saenz M.S., Schaaf C.P, & Potts P.R. (2015). USP7 acts as a molecular rheostat to promote WASH-dependent endosomal protein recycling and is mutated in a human neurodevelopmental disorder. Molecular cell, 59(6), 956-969.